EviCore’s updated coverage guidelines support access to AI-enabled Plaque Analysis to help physicians precisely diagnose and manage patients with coronary artery diseaseMOUNTAIN VIEW, Calif., July 11, ...

Researchers from The University of Western Australia, working with medtech industry partners Artrya, have developed a new, ...

Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive ...

New study details gaps between actual and recommended use of statins and other lipid-lowering drugs—and estimates public ...

Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced it will present new data and technology ...

June 30, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced ... change in over half of patients beyond coronary computed ...

Cardiologists reveal the unexpected symptoms of clogged arteries and underlying heart disease that you should know about.

When coronary computed tomography angiography (CCTA) was introduced, it marked a major advancement with its ability to provide anatomical assessment of the arteries for plaque burden.

Coronary Computed Tomography Angiography (CCTA or Coronary CTA) is a cutting-edge, non-invasive imaging test that provides detailed 3D images of the heart’s blood vessels.

Heart experts say that everyone should have their levels of lipoprotein (a) (Lp(a) measured routinely at least once in life, ...